Revised Comprehensive Guidelines for Management of COVID-19 in Children and Adolescents (below 18 years)

Written By Sharon Mathew

On 20 January 2022 the Ministry of Health and Family Welfare issued revised guidelines for the management of COVID-19 in children and adolescents. Some of these include-

  • Use of antivirals or monoclonal antibodies is not recommended for children less than 18 years of age, irrespective of the severity of infection.

  • For diagnosing MIS-C, caution should be exercised while interpreting an isolated increase in COVID antibodies.

  • The CRP level for diagnosis of MIS-C has been revised as >5mg/dL.

  • If steroids are used, they should be tapered over 10-14 days, subject to clinical improvement.

  • Use of anticoagulants has been revised.

Sharon Mathew
Next

Kerala HC: Private medical colleges collecting fees in advance considered ‘profiteering’